Editas Medicine Inc.

09/12/2024 | Press release | Distributed by Public on 09/12/2024 17:00

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.